Keith Wayne Ward is Chief Development Officer at REATA PHARMACEUTICALS INC (RETA). They have made 10 open-market trades across 1 company since 2018, most recently 2019-02-26.
CIK 0001662394
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RETA | 23,803 | $4.1M |
Shares reported on the most recent Form 4, priced at the 2019-02-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RETA | SELL | 2019-02-26 | 2019-02-27 | $91.62 | $767K | -7.5% | -12.7% | -7.7% |
| RETA | SELL | 2019-02-25 | 2019-02-27 | $91.13 | $3.7M | -7.5% | -12.7% | -7.7% |
| RETA | SELL | 2019-01-31 | 2019-02-01 | $76.81 | $530K | +11.1% | +31.3% | +0.7% |
| RETA | SELL | 2019-01-31 | 2019-02-01 | $76.70 | $318K | +11.1% | +31.3% | +0.7% |
| RETA | SELL | 2019-01-02 | 2019-01-03 | $53.99 | $448K | +36.6% | +45.6% | +74.0% |
| RETA | SELL | 2018-11-07 | 2018-11-08 | $66.97 | $636K | -11.9% | -14.4% | +16.5% |
| RETA | SELL | 2018-11-01 | 2018-11-01 | $59.48 | $283K | -4.1% | +4.7% | +20.3% |
| RETA | SELL | 2018-10-23 | 2018-10-24 | $57.08 | $813K | +11.2% | +5.0% | +32.9% |
| RETA | SELL | 2018-07-05 | 2018-07-09 | $36.62 | $174K | +19.7% | +87.6% | +72.7% |
| RETA | SELL | 2018-06-05 | 2018-06-07 | $36.62 | $2.1M | +11.0% | +5.5% | +136.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.